Our report of the germline variants in TTN and ACTC1 connote the complexity of the possible molecular causes of SCD syndromes and affirm that there are still pathogenic genetic factors we could be facing for the first time, which challenges the prescription of the more appropriate and beneficial treatment. This evidence concerns the gene ACTC1 and Schnyder corneal dystrophy.